Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base
Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…
Biocon Q4 net profit surges 153%, biosimilars, generics drive growth
Biocon, India’s leading biopharmaceutical company, reported a 153 percent year-on-year (YoY) jump in net profit for the fourth quarter of FY25, led by strong performances in its biosimilars and generics…